FR2169113A1 - - Google Patents

Info

Publication number
FR2169113A1
FR2169113A1 FR7302099A FR7302099A FR2169113A1 FR 2169113 A1 FR2169113 A1 FR 2169113A1 FR 7302099 A FR7302099 A FR 7302099A FR 7302099 A FR7302099 A FR 7302099A FR 2169113 A1 FR2169113 A1 FR 2169113A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7302099A
Other languages
French (fr)
Other versions
FR2169113B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP848272A external-priority patent/JPS4885574A/ja
Priority claimed from JP1845972A external-priority patent/JPS4886875A/ja
Priority claimed from JP7237372A external-priority patent/JPS4930379A/ja
Priority claimed from JP7434372A external-priority patent/JPS4931674A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of FR2169113A1 publication Critical patent/FR2169113A1/fr
Application granted granted Critical
Publication of FR2169113B1 publication Critical patent/FR2169113B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7302099A 1972-01-22 1973-01-22 Expired FR2169113B1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP848272A JPS4885574A (de) 1972-01-22 1972-01-22
JP1845972A JPS4886875A (de) 1972-02-24 1972-02-24
JP7237372A JPS4930379A (de) 1972-07-19 1972-07-19
JP7434372A JPS4931674A (de) 1972-07-25 1972-07-25

Publications (2)

Publication Number Publication Date
FR2169113A1 true FR2169113A1 (de) 1973-09-07
FR2169113B1 FR2169113B1 (de) 1977-02-04

Family

ID=27454953

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7302099A Expired FR2169113B1 (de) 1972-01-22 1973-01-22

Country Status (4)

Country Link
DE (1) DE2302866C2 (de)
DK (1) DK139868C (de)
FR (1) FR2169113B1 (de)
GB (1) GB1430961A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956341A (en) * 1974-02-21 1976-05-11 Smithkline Corporation 1,3,5-Tricarbo-1,4-dihydropyridines
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
SU706410A1 (ru) * 1978-01-11 1979-12-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср 2,6-Диметил-3,5-дикарбметокси-4(0-дифторметоксифенил)-1,4-дигидропиридин,обладающий выраженной гипотензивной активностью и оказывающий действие на функции вегетативной нервной системы
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
IT1097538B (it) * 1978-07-17 1985-08-31 Medea Res Srl Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino)
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4546186A (en) * 1983-12-14 1985-10-08 American Home Products Corporation 1,4,5,6,7,8-Hexahydro-2-methyl-5-oxo-4-(2-thiazolyl)-3-quinoline carboxylic acid 2-methyl(phenylmethyl)amino ethyl ester and pharmaceutically acceptable salts
EP0330470A3 (de) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. Gegen Tumorzellen verwendbare 1,4-Dihydropyridin-Derivate
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
DE4430092A1 (de) 1994-08-25 1996-02-29 Bayer Ag 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE4444864A1 (de) * 1994-12-16 1996-06-20 Bayer Ag Verwendung von 5-Acyl-1,4-dihydropyridinen
EP1108710A4 (de) * 1998-07-23 2001-11-21 Chen Ing Jun Guaiacoxypropanolamine mit alpha/beta-adrenerger hemmaktivität

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
FR2025618A1 (de) * 1968-12-07 1970-09-11 Bayer Ag
FR2051515A1 (de) * 1969-05-10 1971-04-09 Bayer Ag
DE2005116A1 (de) * 1970-02-05 1971-09-02 Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen Neue 1,4 Dihydropyridindenvate
FR2081373A1 (de) * 1969-12-17 1971-12-03 Bayer Ag
FR2081452A1 (de) * 1970-01-24 1971-12-03 Bayer Ag
FR2081372A1 (de) * 1969-12-17 1971-12-03 Bayer Ag
FR2085727A1 (de) * 1970-03-20 1971-12-31 Bayer Ag

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963738A1 (de) * 1969-12-19 1971-06-24 Semikron Gleichrichterbau Verfahren zur Herstellung von Selengleichrichterplatten

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
FR2025618A1 (de) * 1968-12-07 1970-09-11 Bayer Ag
FR2051515A1 (de) * 1969-05-10 1971-04-09 Bayer Ag
FR2081373A1 (de) * 1969-12-17 1971-12-03 Bayer Ag
FR2081372A1 (de) * 1969-12-17 1971-12-03 Bayer Ag
FR2081452A1 (de) * 1970-01-24 1971-12-03 Bayer Ag
DE2005116A1 (de) * 1970-02-05 1971-09-02 Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen Neue 1,4 Dihydropyridindenvate
FR2085727A1 (de) * 1970-03-20 1971-12-31 Bayer Ag

Also Published As

Publication number Publication date
DE2302866C2 (de) 1988-01-28
DK139868C (da) 1979-10-08
GB1430961A (en) 1976-04-07
DK139868B (da) 1979-05-07
FR2169113B1 (de) 1977-02-04
DE2302866A1 (de) 1973-08-02

Similar Documents

Publication Publication Date Title
JPS4948680A (de)
FR2279397B1 (de)
JPS5222201B2 (de)
JPS5227705Y2 (de)
JPS5147651Y2 (de)
JPS5231217B2 (de)
JPS4938016U (de)
JPS5016889Y2 (de)
JPS4933525U (de)
JPS4967502A (de)
JPS4915758U (de)
CH566079A5 (de)
CH564662A5 (de)
CH564657A5 (de)
AU5074572A (de)
CH563640A5 (de)
CH563529A5 (de)
CH566745A5 (de)
CH563070A5 (de)
CH562838A5 (de)
BG20528A3 (de)
CH562062A5 (de)
CH567322A5 (de)
CH574150A5 (de)
CH568472A5 (de)

Legal Events

Date Code Title Description
ST Notification of lapse